The US Epilepsy Market is forecast to grow from USD 1.321 billion in 2025 to USD 2.3 billion by 2035. Market Research Future estimates a 5.7% CAGR during the forecast period, with rising demand for innovative therapies and improvements in epilepsy diagnosis supporting market expansion.

Diagnosis is an important component of epilepsy care, with electroencephalogram representing the largest diagnosis method segment. Medical imaging is identified as the fastest-growing method, as MRI and CT technologies provide additional anatomical information that can complement EEG-based assessments.

Patient age is another important market segment. Children represent the largest age group in the report, while adults are identified as the fastest-growing group. Improvements in diagnosis, increased awareness, and an aging population are contributing to changing demand across different patient demographics.

Research and development are also influencing the US market. Pharmaceutical companies are developing new antiepileptic therapies, while healthcare organizations are exploring neuromodulation, personalized medicine, digital monitoring, and telehealth. Government research funding and patient advocacy initiatives further support awareness and innovation within the epilepsy care ecosystem.

Explore additional reports to understand evolving market landscapes:

Medical Billing Market Size

Medical Billing Market Share

Medical Cannabis Market Trends

Medical Cannabis Market Growth

Medical Cannabis Market Demand